Previous Article | Next Article 
Molecular and Cellular Biology, June 2007, p. 4328-4339, Vol. 27, No. 12
0270-7306/07/$08.00+0 doi:10.1128/MCB.00153-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
Glycogen Synthase Kinase 3
and 3ß Mediate a Glucose-Sensitive Antiapoptotic Signaling Pathway To Stabilize Mcl-1
Yuxing Zhao,1
Brian J. Altman,1
Jonathan L. Coloff,1
Catherine E. Herman,1,2
Sarah R. Jacobs,1
Heather L. Wieman,1
Jessica A. Wofford,1
Leah N. Dimascio,1
Olga Ilkayeva,1,2
Ameeta Kelekar,3
Tannishtha Reya,1 and
Jeffrey C. Rathmell1,2,4*
Department of Pharmacology and Cancer Biology,1
Sarah W. Stedman Nutrition and Metabolism Center,2
Department of Immunology, Duke University Medical Center, Durham, North Carolina 27710,4
Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota 554553
Received 26 January 2007/
Returned for modification 2 March 2007/
Accepted 9 March 2007
Glucose uptake and utilization are growth factor-stimulated processes that are frequently upregulated in cancer cells and that correlate with enhanced cell survival. The mechanism of metabolic protection from apoptosis, however, has been unclear. Here we identify a novel signaling pathway initiated by glucose catabolism that inhibited apoptotic death of growth factor-deprived cells. We show that increased glucose metabolism protected cells against the proapoptotic Bcl-2 family protein Bim and attenuated degradation of the antiapoptotic Bcl-2 family protein Mcl-1. Maintenance of Mcl-1 was critical for this protection, as glucose metabolism failed to protect Mcl-1-deficient cells from apoptosis. Increased glucose metabolism stabilized Mcl-1 in both cell lines and primary lymphocytes via inhibitory phosphorylation of glycogen synthase kinase 3
and 3ß (GSK-3
/ß), which otherwise promoted Mcl-1 degradation. While a number of kinases can phosphorylate and inhibit GSK-3
/ß, we provide evidence that protein kinase C may be stimulated by glucose-induced alterations in diacylglycerol levels or distribution to phosphorylate GSK-3
/ß, maintain Mcl-1 levels, and inhibit cell death. These data provide a novel nutrient-sensitive mechanism linking glucose metabolism and Bcl-2 family proteins via GSK-3 that may promote survival of cells with high rates of glucose utilization, such as growth factor-stimulated or cancerous cells.
* Corresponding author. Mailing address: Department of Pharmacology and Cancer Biology, DUMC Box 3813, Durham, NC 27710. Phone: (919) 681-1084. Fax: (919) 668-6044. E-mail:
jeff.rathmell{at}duke.edu
Published ahead of print on 19 March 2007.
Molecular and Cellular Biology, June 2007, p. 4328-4339, Vol. 27, No. 12
0270-7306/07/$08.00+0 doi:10.1128/MCB.00153-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Chang, M., Hamilton, J. A., Scholz, G. M., Elsegood, C. L.
(2009). Glycolytic control of adjuvant-induced macrophage survival: role of PI3K, MEK1/2, and Bcl-2. J. Leukoc. Biol.
85: 947-956
[Abstract]
[Full Text]
-
Altman, B. J., Wofford, J. A., Zhao, Y., Coloff, J. L., Ferguson, E. C., Wieman, H. L., Day, A. E., Ilkayeva, O., Rathmell, J. C.
(2009). Autophagy Provides Nutrients but Can Lead to Chop-dependent Induction of Bim to Sensitize Growth Factor-deprived Cells to Apoptosis. Mol. Biol. Cell
20: 1180-1191
[Abstract]
[Full Text]
-
Boztug, K., Appaswamy, G., Ashikov, A., Schaffer, A. A., Salzer, U., Diestelhorst, J., Germeshausen, M., Brandes, G., Lee-Gossler, J., Noyan, F., Gatzke, A.-K., Minkov, M., Greil, J., Kratz, C., Petropoulou, T., Pellier, I., Bellanne-Chantelot, C., Rezaei, N., Monkemoller, K., Irani-Hakimeh, N., Bakker, H., Gerardy-Schahn, R., Zeidler, C., Grimbacher, B., Welte, K., Klein, C.
(2009). A Syndrome with Congenital Neutropenia and Mutations in G6PC3. NEJM
360: 32-43
[Abstract]
[Full Text]
-
Zhao, Y., Coloff, J. L., Ferguson, E. C., Jacobs, S. R., Cui, K., Rathmell, J. C.
(2008). Glucose Metabolism Attenuates p53 and Puma-dependent Cell Death upon Growth Factor Deprivation. J. Biol. Chem.
283: 36344-36353
[Abstract]
[Full Text]
-
Ohori, K., Miura, T., Tanno, M., Miki, T., Sato, T., Ishikawa, S., Horio, Y., Shimamoto, K.
(2008). Ser9 phosphorylation of mitochondrial GSK-3{beta} is a primary mechanism of cardiomyocyte protection by erythropoietin against oxidant-induced apoptosis. Am. J. Physiol. Heart Circ. Physiol.
295: H2079-H2086
[Abstract]
[Full Text]
-
MacIver, N. J., Jacobs, S. R., Wieman, H. L., Wofford, J. A., Coloff, J. L., Rathmell, J. C.
(2008). Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival. J. Leukoc. Biol.
84: 949-957
[Abstract]
[Full Text]
-
Allard, D., Figg, N., Bennett, M. R., Littlewood, T. D.
(2008). Akt Regulates the Survival of Vascular Smooth Muscle Cells via Inhibition of FoxO3a and GSK3. J. Biol. Chem.
283: 19739-19747
[Abstract]
[Full Text]
-
Kavalerchik, E., Goff, D., Jamieson, C. H.M.
(2008). Chronic Myeloid Leukemia Stem Cells. JCO
26: 2911-2915
[Abstract]
[Full Text]
-
Wang, X., Chen, W., Zeng, W., Bai, L., Tesfaigzi, Y., Belinsky, S. A., Lin, Y.
(2008). Akt-mediated eminent expression of c-FLIP and Mcl-1 confers acquired resistance to TRAIL-induced cytotoxicity to lung cancer cells. Molecular Cancer Therapeutics
7: 1156-1163
[Abstract]
[Full Text]
-
Jacobs, S. R., Herman, C. E., MacIver, N. J., Wofford, J. A., Wieman, H. L., Hammen, J. J., Rathmell, J. C.
(2008). Glucose Uptake Is Limiting in T Cell Activation and Requires CD28-Mediated Akt-Dependent and Independent Pathways. J. Immunol.
180: 4476-4486
[Abstract]
[Full Text]
-
Wofford, J. A., Wieman, H. L., Jacobs, S. R., Zhao, Y., Rathmell, J. C.
(2008). IL-7 promotes Glut1 trafficking and glucose uptake via STAT5-mediated activation of Akt to support T-cell survival. Blood
111: 2101-2111
[Abstract]
[Full Text]
-
Guo, X., Ramirez, A., Waddell, D. S., Li, Z., Liu, X., Wang, X.-F.
(2008). Axin and GSK3- control Smad3 protein stability and modulate TGF- signaling. Genes Dev.
22: 106-120
[Abstract]
[Full Text]
-
Jamieson, C. H.
(2008). Chronic Myeloid Leukemia Stem Cells. ASH Education Book
2008: 436-442
[Abstract]
[Full Text]